(Q60449339)
Statements
Elderly patients benefit from second-line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed compared with docetaxel in patients with previously treated advanced non-small-cell lung cancer (English)
Corey Langer
Nasser Hanna
Frances Shepherd
Binh Nguyen
Sofia Paul
Patrick McAndrews
Glen J Weiss
Rafael Rosell
Lawrence H Einhorn
Paul A Bunn
1 September 2006